Dechra Pharmaceuticals PLC — Board/Management Information 2013

Nov 20, 2013

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 5082T

Dechra Pharmaceuticals PLC

20 November 2013

20 November 2013

Dechra® Pharmaceuticals PLC

("Dechra" or "the Company") 

Director's Declaration

In accordance with Listing Rule 9.6.14(2) Dechra announces that Ishbel Macpherson, Senior Independent Non-Executive Director of Dechra, has been appointed as the Senior Independent Non-Executive Director of Bonmarché Holdings PLC. Bonmarché Holdings PLC was admitted to AIM on 20 November 2013.

For further information

Zoe Goulding, Company Secretary            

Telephone number: 01606 814730

About Dechra

Dechra is an international specialist veterinary pharmaceuticals business.  Its expertise is in the development, manufacturing and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDNPGGCUGUPWGGU